Exact Mass: 577.1512233999999
Exact Mass Matches: 577.1512233999999
Found 20 metabolites which its exact mass value is equals to given mass value 577.1512233999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clazosentan
C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].
sodium 4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate
NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE
C19H34NNa2O14P (577.1512233999999)
NEU5AC ALPHA(2-3)GAL BETA MP GLYCOSIDE
C24H35NO15 (577.2006600000001)
Clazosentan
C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].
6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate
C27H29O14- (577.1557233999999)
2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester
(3S,3S,4R,5S)-5-(2-hydroxyethyl)-5-iodo-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-1-prop-2-enyl-2-spiro[indole-3,2-oxolane]one
vitexin 2-O-alpha-L-rhamnoside(1-)
C27H29O14- (577.1557233999999)
The conjugate base of vitexin 2-O-alpha-L-rhamnoside arising from deprotonation of the OH group at position 7 on the chromene.
vitexin 2-O-beta-L-rhamnoside(1-)
A flavonoid oxoanion that is the conjugate base of vitexin 2-O-beta-L-rhamnoside obtained by deprotonation of the OH group at position 7 on the chromene. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).